Literature DB >> 15014621

Psychiatric Uses of Newer Anticonvulsants.

Timothy R. Berigan1.   

Abstract

Year:  2001        PMID： 15014621      PMCID： PMC181167          DOI： 10.4088/pcc.v03n0207

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  43 in total

1.  Gabapentin in the Treatment of Posttraumatic Stress Disorder.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06

2.  A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence.

Authors:  T I Mueller; R L Stout; S Rudden; R A Brown; A Gordon; D A Solomon; P R Recupero
Journal:  Alcohol Clin Exp Res       Date:  1997-02       Impact factor: 3.455

3.  Gabapentin for disruptive behaviour in an elderly demented patient.

Authors:  G Goldenberg; K Kahaner; N Basavaraju; S Rangu
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

4.  Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.

Authors:  G Corá-Locatelli; B D Greenberg; J Martin; D L Murphy
Journal:  J Clin Psychiatry       Date:  1998-09       Impact factor: 4.384

5.  Gabapentin in geriatric psychiatry patients.

Authors:  L J Sheldon; R J Ancill; S G Holliday
Journal:  Can J Psychiatry       Date:  1998-05       Impact factor: 4.356

6.  Gabapentin in the treatment of bipolar disorder.

Authors:  C B Schaffer; L C Schaffer
Journal:  Am J Psychiatry       Date:  1997-02       Impact factor: 18.112

7.  Gabapentin abuse in a cocaine user: implications for treatment?

Authors:  J S Markowitz; R Finkenbine; H Myrick; L King; W H Carson
Journal:  J Clin Psychopharmacol       Date:  1997-10       Impact factor: 3.153

8.  Tiagabine appears not to be efficacious in the treatment of acute mania.

Authors:  H Grunze; A Erfurth; A Marcuse; B Amann; C Normann; J Walden
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

9.  The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.

Authors:  C L Bowden; J R Calabrese; S L McElroy; L J Rhodes; P E Keck; J Cookson; J Anderson; C Bolden-Watson; J Ascher; E Monaghan; J Zhou
Journal:  Biol Psychiatry       Date:  1999-04-15       Impact factor: 13.382

10.  Treatment of social phobia with gabapentin: a placebo-controlled study.

Authors:  A C Pande; J R Davidson; J W Jefferson; C A Janney; D J Katzelnick; R H Weisler; J H Greist; S M Sutherland
Journal:  J Clin Psychopharmacol       Date:  1999-08       Impact factor: 3.153
View more
  4 in total

1.  Oxcarbazepine in Bipolar Disorder.

Authors:  James W. Jefferson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

2.  Dr. Berigan Replies.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

3.  Uses of Newer Anticonvulsants: An Update.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-10

Review 4.  Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines.

Authors:  Mervin Chávez-Castillo; Victoria Núñez; Manuel Nava; Ángel Ortega; Milagros Rojas; Valmore Bermúdez; Joselyn Rojas-Quintero
Journal:  Adv Pharmacol Sci       Date:  2019-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.